IL-13Rα2 membrane and soluble isoforms differ in humans and mice

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7870-7876

  Chen, Weiguo ^a   Sivaprasad, Umasundari ^a   Tabata, Yasuhiro ^a   Gibson, Aaron M ^a   Stier, Matthew T ^a   Finkelman, Fred D ^a,b   Hershey, Gurjit K Khurana ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 13 RECEPTOR ALPHA2; NEUTROPHIL COLLAGENASE; SMALL INTERFERING RNA; ISOPROTEIN; MEMBRANE PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE; SOLUBILITY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CELL LINE; CELL STRAIN U937; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MOUSE MUTANT;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; SOLUBILITY; U937 CELLS;

EID: 76249119277     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901028     Document Type: Article

References (31)

1. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261. (Pubitemid 29004074)
2. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263. (Pubitemid 29004075)
3. Aman, M. J., N. Tayebi, N. I. Obiri, R. K. Puri, W. S. Modi, and W. J. Leonard. 1996. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J. Biol. Chem. 271: 29265-29270. (Pubitemid 26382639)
4. Caput, D., P. Laurent, M. Kaghad, J. M. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 271: 16921-16926.
5. Hilton, D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93: 497-501. (Pubitemid 26038184)
6. Miloux, B., P. Laurent, O. Bonnin, J. Lupker, D. Caput, N. Vita, and P. Ferrara. 1997. Cloning of the human IL-13R α1 chain and reconstitution with the IL4Rα of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401: 163-166. (Pubitemid 27056108)
7. Zhang, J. G., D. J. Hilton, T. A. Willson, C. McFarlane, B. A. Roberts, R. L. Moritz, R. J. Simpson, W. S. Alexander, D. Metcalf, and N. A. Nicola. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein: evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor α-chains. J. Biol. Chem. 272: 9474-9480.
8. Ramalingam, T. R., J. T. Pesce, F. Sheikh, A. W. Cheever, M. M. Mentink-Kane, M. S. Wilson, S. Stevens, D. M. Valenzuela, A. J. Murphy, G. D. Yancopoulos, et al. 2008. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chain. Nat Immunol. 9: 25-33.
9. Munitz, A., E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg. 2008. Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl. Acad. Sci. USA 105: 7240-7245.
10. Donaldson, D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Finnerty, S. L. Henderson, R. M. O'Hara, Jr., D. R. Beier, K. J. Turner, C. R. Wood, and M. Collins. 1998. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 161: 2317-2324.
11. Wood, N., M. J. Whitters, B. A. Jacobson, J. Witek, J. P. Sypek, M. Kasaian, M. J. Eppihimer, M. Unger, T. Tanaka, S. J. Goldman, et al. 2003. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α2. J. Exp. Med. 197: 703-709.
12. Chiaramonte, M. G., M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, and T. A. Wynn. 2003. Regulation and function of the interleukin 13 receptor α2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197: 687-701.
13. Fichtner-Feigl, S., W. Strober, K. Kawakami, R. K. Puri, and A. Kitani. 2006. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 12: 99-106.
14. Fichtner-Feigl, S., C. A. Young, A. Kitani, E. K. Geissler, H. J. Schlitt, and W. Strober. 2008. IL-13 signaling via IL-13R α2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 135: 2003-2013, 2013 e2001-e2007.
15. Tabata, Y., W. Chen, M. R. Warrier, A. M. Gibson, M. O. Daines, and G. K. Hershey. 2006. Allergy-driven alternative splicing of IL-13 receptor α2 yields distinct membrane and soluble forms. J. Immunol. 177: 7905-7912.
16. Chen, W., Y. Tabata, A. M. Gibson, M. O. Daines, M. R. Warrier, M. Wills-Karp, and G. K. Hershey. 2008. Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor α2 in vivo. J. Allergy Clin. Immunol. 122: 625-632.
17. Daines, M. O., W. Chen, Y. Tabata, B. A. Walker, A. M. Gibson, J. A. Masino, M. R. Warrier, C. L. Daines, S. E. Wenzel, and G. K. Hershey. 2007. Allergen-dependent solubilization of IL-13 receptor α2 reveals a novel mechanism to regulate allergy. J. Allergy Clin. Immunol. 119: 375-383.
18. Leigh, R., R. Ellis, J. Wattie, D. D. Donaldson, and M. D. Inman. 2004. Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice? Am. J. Respir. Crit. Care Med. 170: 851-856.
19. Morimoto, M., A. Zhao, K. B. Madden, H. Dawson, F. D. Finkelman, M. Mentink-Kane, J. F. Urban, Jr., T. A. Wynn, and T. Shea-Donohue. 2006. Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J. Immunol. 176: 491-495.
20. Mentink-Kane, M. M., A. W. Cheever, R. W. Thompson, D. M. Hari, N. B. Kabatereine, B. J. Vennervald, J. H. Ouma, J. K. Mwatha, F. M. Jones, D. D. Donaldson, et al. 2004. IL-13 receptor α2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc. Natl. Acad. Sci. USA 101: 586-590.
21. Khodoun, M., C. C. Lewis, J. Q. Yang, T. Orekov, C. Potter, T. Wynn, M. Mentink-Kane, G. K. Hershey, M. Wills-Karp, and F. D. Finkelman. 2007. Differences in expression, affinity, and function of soluble (s) IL-4Rα and sIL-13Rα2 suggest opposite effects on allergic responses. J. Immunol. 179: 6429-6438.
22. Daines, M. O., Y. Tabata, B. A. Walker, W. Chen, M. R. Warrier, S. Basu, and G. K. Hershey. 2006. Level of expression of IL-13Rα2 impacts receptor distribution and IL-13 signaling. J. Immunol. 176: 7495-7501.
23. Reynolds, A., D. Leake, Q. Boese, S. Scaringe, W. S. Marshall, and A. Khvorova. 2004. Rational siRNA design for RNA interference. Nat. Biotechnol. 22: 326-330. (Pubitemid 38295766)
24. Ovcharenko, I., M. A. Nobrega, G. G. Loots, and L. Stubbs. 2004. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 32: W280-W286. (Pubitemid 38997344)
25. O'Toole, M., H. Legault, R. Ramsey, T. A. Wynn, and M. T. Kasaian. 2008. A novel and sensitive ELISA reveals that the soluble form of IL-13R-α2 is not expressed in plasma of healthy or asthmatic subjects. Clin. Exp. Allergy 38: 594-601. (Pubitemid 351406063)
26. Prikk, K., P. Maisi, E. Pirila, M. A. Reintam, T. Salo, T. Sorsa, and R. Sepper. 2002. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab. Invest. 82: 1535-1545. (Pubitemid 35332912)
27. Vernooy, J. H., J. H. Lindeman, J. A. Jacobs, R. Hanemaaijer, and E. F. Wouters. 2004. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 126: 1802-1810.
28. Zheng, L., W. K. Lam, G. L. Tipoe, I. H. Shum, C. Yan, R. Leung, J. Sun, G. C. Ooi, and K. W. Tsang. 2002. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur. Respir. J. 20: 170-176. (Pubitemid 34822940)
29. Demedts, I. K., G. G. Brusselle, K. R. Bracke, K. Y. Vermaelen, and R. A. Pauwels. 2005. Matrix metalloproteinases in asthma and COPD. Curr. Opin. Pharmacol. 5: 257-263.
30. Gueders, M. M., M. Balbin, N. Rocks, J. M. Foidart, P. Gosset, R. Louis, S. Shapiro, C. Lopez-Otin, A. Noel, and D. D. Cataldo. 2005. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J. Immunol. 175: 2589-2597.
31. Kuula, H., T. Salo, E. Pirila, A. M. Tuomainen, M. Jauhiainen, V. J. Uitto, L. Tjaderhane, P. J. Pussinen, and T. Sorsa. 2009. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalisinduced periodontitis. Infect. Immun. 77: 850-859.